- Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
Jung Yoo et al, 2022, Experimental & Molecular Medicine CrossRef - Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
Yi-Chao Zheng et al, 2019, European Journal of Medicinal Chemistry CrossRef - Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose et al, 2020, Cancers CrossRef - Histone demethylase lysine demethylase 5B in development and cancer
Mengjiao Han et al, 2017, Oncotarget CrossRef - Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
Kuang-Tai Kuo et al, 2018, Clinical Epigenetics CrossRef - Targeting JARID1B’s demethylase activity blocks a subset of its functions in oral cancer
Nicole D. Facompre et al, 2018, Oncotarget CrossRef - The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
Dawid Dorna et al, 2022, Cells CrossRef - Overcoming radio-resistance in esophageal squamous cell carcinoma via hypermethylation of PIK3C3 promoter region mediated by KDM5B loss
Xiaobo Wang et al, 2022, Journal of Radiation Research CrossRef - Prevention of inorganic arsenic induced squamous cell carcinoma of the skin in Swiss albino mice by black tea through epigenetic modulation
Archismaan Ghosh et al, 2022, Heliyon CrossRef - Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu et al, 2020, European Journal of Medicinal Chemistry CrossRef - KDM5 Lysine Demethylases in Pathogenesis, from Basic Science Discovery to the Clinic
Shang-Min Zhang et al, 2023, Targeting Lysine Demethylases in Cancer and Other Human Diseases CrossRef